← Back to All Stocks

Soligenix, Inc. (SNGX) Analysis

Generated on: 2025-07-31 14:08:03 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
⚠️ VERY LOW FLOAT STOCK - 3,263,693 shares

Analysis Values

Current Price
$1.30
Predicted Price
$1.91
Expected Return
16.59%
Confidence Score
0.83
RSI (14)
83.03 (sell)
MACD
0.02
Volume
106,960,295
Float Shares
3,263,693
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
251

SNGX

Soligenix, Inc.
16.59%
Price: $1.30
Confidence: 0.83
News
Low Float
Last updated: 2025-07-31 14:08:02

Technical Analysis

RSI: 83.03 (sell)
MACD: 0.02
Technical Analysis Graph

Risk Analysis

Volatility
125.53%
Max Drawdown
-78.38%
Beta
1.0
Risk Score
100

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
Soligenix Drug Matches FDA-Approved Amgen Therapy In Rare Disease Trial
Benzinga - 2025-07-31 13:00
Soligenix Inc. (NASDAQ:SNGX) shares surged on Thursday as the company announced positive results from its Phase 2a proof-of-concept study of SGX945 (dusquetide) in Behçet’s disease, a rare and chronic inflammatory condition. The session volume reached 28.71 million shares, significantly above the stock’s average daily volume of approximately 905,000, according to Benzinga Pro. The company reported that SGX945 achieved the trial’s primary goal of demonstrating biological efficacy in treating oral

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.